课题基金 / 基金详情

Imaging Tumor Blood Vessels in Bone Metastases from Breast Cancer

Imaging Tumor Blood Vessels in Bone Metastases from Breast Cancer
乳腺癌骨转移中的肿瘤血管成像
批准号:
6931878
负责人:
WADIH ARAP
金额:
$33.22万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-09-10 至 2007-08-31

项目摘要

项目成果

WADIH ARAP的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): We hypothesize that specific vascular addresses within tumor vasculature can be exploited for imaging and detection of metastatic breast carcinoma; our goal is to use these biochemical differences to develop targeted therapies. Here, we propose to investigate the molecular diversity of angiogenic vasculature during the tumor progression and metastases of breast cancer. Our specific aims are (i) to identify and characterize suitable markers of bone marrow metastases as targets for vascular imaging; (ii) to study the localization and distribution of the probes and respective receptors by imaging systems; (iii) to design, synthesize and validate devices for targeted imaging by developing novel tools for intravital imaging at the protein-protein level (such as engineered phage particles, recombinant proteins, nanoshells, or fluorescent microspheres). The most efficient targeting systems will be tested and validated in vivo in mouse models of bone marrow metastases. If successful, novel strategies to image metastatic breast cancer will be derived from this application. The approaches utilized in this application can be used to characterize the tumor microenvironment in breast cancer, changes and localization of receptors in the vascular endothelium of tumor blood vessels during breast cancer progression. In addition, probes that target breast cancer vasculature will be developed as delivery tools and will likely enhance effectiveness of current imaging technology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Designing a transcriptome-based, targeted theranostic platform for prostate cancer
Designing a transcriptome-based, targeted theranostic platform for prostate cancer
A Targeted Nanomedicine Prototype Against Enzalutamide-resistant Prostate Cancer
A Targeted Nanomedicine Prototype Against Enzalutamide-resistant Prostate Cancer